Bibliography
- RIEUSSET J, TOURI F, MICHALIK L et al.: A new selective perwdsome proliferator-activated receptor y antagonist with antiobesity and antidiabetic activity. Mai Endocrinol (2002) 16:2628–2644.
- MORI Y, MURAKAWA Y, OKADA K et al.: Effect of troglitazone on body fat distribution in Type 2 diabetic patients. Diabetes Care (1999) 22:908–912.
- HIROSE H, KAWAI T, YAMAMOTO Y et al.: Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with Type 2 diabetes. Metabolism (2002) 51:314–317.
- KERSEN S, DESVERGNE B, WAHLI W: Roles of PPARs in health and disease. Nature (2000) 405:421–424.
- DEEB SS, FAJA L, NEMOTO M et al.: A Pro12Ala substitution in PPARy2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20:284–287.
- KUBOTA N, TERAUCHI Y, MIKI H et al.: PPARy mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mai Cell (1999) 4:597–609.
- OBERFIELD JL, COLLINS JL, HOLMES CP et al: A peroxisome proliferator-activated receptor y ligand inhibits adipocyte differentiation. Proc. Nati Acad. Sci. USA (1999) 96:6102–6106.
- WRIGHT MH, CLISH CB, MIKAMI T et al.: A synthetic antagonist for the perwdsome proliferator-activated receptor gamma inhibits adipocyte differentiation. J. Biol. Chem. (2000) 275:1873–1877.
- MUKHERJEE R, HOENER PA, JOW L et al.: A selective peroxisome proliferator-activated receptor y (PPARy) modulator bocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mal Endocrinol (2000) 14:1425–1433.
- CAMP HS, CHAUDRY A, LEFF T: A novel potent antagonist of perwdsome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes. Endocrinology (2001) 142:3207–3213.
- YAMAUCHI T, WAKI H, KAMON J et al.: Inhibition of RXR and PPARy ameliorates diet-induced obesity and Type 2 diabetes. Clin. Invest. 108:1001-1013.
- FROHBECK G, GOMEZ-AMBROSI, MURUZÁBAL FJ, BURRELL MA: The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. I Physiol Endocrinol Metab. 280:E827–E847.
- ADAMSON DJ, FREW D, TATOUD R, WOLF CR, PALMER CN: Diclofenac antagonizes perwdsome proliferator-activated receptor-7 signaling. Mal Pharmacol (2002) 61:7–12.